Mark A. Matson, Eran Schenker, Michal Stein, Vladislava Zamfirova, Huy-Binh Nguyen, & Garrett E. Bergman. (2020). Safety and efficacy results of simulated post-exposure prophylaxis with human immune globulin (HRIG; KEDRAB) co-administered with active vaccine in healthy subjects: A comparative phase 2/3 trial. Taylor & Francis Group.
Chicago Style (17th ed.) CitationMark A. Matson, Eran Schenker, Michal Stein, Vladislava Zamfirova, Huy-Binh Nguyen, and Garrett E. Bergman. Safety and Efficacy Results of Simulated Post-exposure Prophylaxis with Human Immune Globulin (HRIG; KEDRAB) Co-administered with Active Vaccine in Healthy Subjects: A Comparative Phase 2/3 Trial. Taylor & Francis Group, 2020.
MLA (9th ed.) CitationMark A. Matson, et al. Safety and Efficacy Results of Simulated Post-exposure Prophylaxis with Human Immune Globulin (HRIG; KEDRAB) Co-administered with Active Vaccine in Healthy Subjects: A Comparative Phase 2/3 Trial. Taylor & Francis Group, 2020.